Abstract
Pathogenesis of asthma involves various cytokines, which could be a target for asthma therapy. So far, biological agents targeting IL-4, IL-5 and IL-12 have not been successful, while treatment with humanized anti-IgE antibody has been shown to be beneficial for severe athmatics.